Untreated, severe, symptomatic aortic stenosis is associated with a dismal prognosis. The
only treatment shown to improve survival is aortic valve replacement; however, before …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Device embolization is a rare complication of transcatheter structural heart interventions.
Although the majority of device embolizations can be treated in a semielective manner …

Objectives: This study sought to develop a robust and definitive risk model for new
permanent pacemaker implantation (PPMI) after SAPIEN 3 (third generation balloon …

Background: Two competing transcatheter aortic valve replacement (TAVR) technologies
are currently available. Head-to-head comparisons of the relative performances of these 2 …

Objectives: The aim of this study was to analyze the frequency and outcomes of patients who
underwent transsubclavian or transaxillary (TAx) transcatheter aortic valve replacement …

Abstract The American College of Cardiology collaborated with the American Association for
Thoracic Surgery, American Heart Association, American Society of Echocardiography …

Background Greater early left ventricular mass index (LVMi) regression is associated with
fewer hospitalizations 1 year after transcatheter aortic valve replacement (TAVR). The …

Background: Surgical aortic valve replacement using conventional biological valves (CBVs)
is the standard of care for treatment of old patients with aortic valve disease. Recently, rapid …

Aims Transcatheter aortic valve implantation (TAVI) has developed from a procedure for
patients with aortic stenosis inoperable or high risk for surgery, into a treatment option even …